×
ADVERTISEMENT

MAY 30, 2024

New Developments in Hemophilia Gene Therapy


Originally published by our sister publication Specialty Pharmacy Continuum

Adrienne Brennan, PharmD, CSP
Clinical Program Manager
Walgreens Specialty Pharmacy
Pittsburgh, Pennsylvania

Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, leading to spontaneous or excessive bleeding after injury. The disease affects as many as 33,000 males in the United States.1,2 Because of the X-linked pattern of inheritance, almost all cases occur in